Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported third quarter 2024 earnings results today. Sales increased 2.6% year-over-year to $36.4 billion. Sales rose
Key highlights from Walgreens Boots Alliance’s (WBA) Q3 2024 earnings results
![](https://cdn.news.alphastreet.com/wp-content/uploads/2024/06/Walgreens-Boots-Alliance-Q3-2024-Earnings-Infographic-700x400.jpg)
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported third quarter 2024 earnings results today. Sales increased 2.6% year-over-year to $36.4 billion. Sales rose
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment.
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the second quarter of 2024. Net profit, on
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring
Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy experience. Having
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net profit, on
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is scheduled to report first-quarter earnings on Thursday, amid expectations for a mixed outcome. The retail
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the first
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2023 earnings results today. Sales increased 9.2% year-over-year to $35.4 billion. Sales growth
Retail pharmacy chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is on the path to a transformation as it looks to align the
Healthcare conglomerate UnitedHealth Group (NYSE: UNH) has a good track record of effectively navigating challenges. The company's diversified offerings help it deliver
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter of fiscal
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the latest such
Key highlights from Cigna Corporation (CI) Q2 2023 Earnings Concall Q&A Highlights: [00:21:37] Scott Fidel with Stephens asked how are underlying utilization
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the second quarter of
Healthcare company The Cigna Group (NYSE: CI) on Thursday reported a 7% increase in revenues for the second quarter of 2023. The
Over the years, UnitedHealth Group Incorporated (NYSE: UNH) has grown into a diversified healthcare conglomerate as it keeps investing in the business
Drugstore chain Rite Aid Corporation (NYSE: RAD) announced first-quarter results, reporting lower revenues and a narrower adjusted loss. First-quarter loss, excluding special
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Tuesday said its third-quarter sales rose 9%. As a result, the healthcare service company’s adjusted